Simulation and Comparison of Progression-Free Survival (Pfs) Among Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Therapy
Chouaid, C, Walzer, S, Lister, J, Gultyaev, D, Vergnenegre, A, de Marinis, F, Meng, J, de Castro, J, Crott, R, Kleman, M, Ngoh, C.A
Published in Value in health (01.05.2014)
Published in Value in health (01.05.2014)
Get full text
Journal Article
P63 Cost Effectiveness of Cabozantinib Plus Nivolumab As First-Line Treatment for Renal Cell Carcinoma
Marciniak, A., Gultyaev, D., Orbzut, G., Mollon, P., Wallace, J.F.
Published in Value in health (01.07.2022)
Published in Value in health (01.07.2022)
Get full text
Journal Article
TT3 MEDICARE BUDGET IMPACT ANALYSIS OF CONVECTIVE WATER VAPOR ENERGY THERAPY COMPARED TO PROSTATIC URETHRAL LIFT FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Chughtai, B., Neeser, K., Rojanasarot, S., Amorosi, S.L., Agrawal, M., Gultyaev, D., Minshall, M., Shore, N.D.
Published in Value in health (01.05.2020)
Published in Value in health (01.05.2020)
Get full text
Journal Article
PRO66 PHARMACOKINETIC PARAMETER DRIVEN OUTCOMES MODEL PREDICTS A REDUCTION IN BLEEDS WITH OCTOCOG ALFA VERSUS ANTIHEMOPHILIC FACTOR (RECOMBINANT)
O'Hara, J., Gultyaev, D., Asghar, S., Duval, V., Kessabi, S., Vashi, P., Solms, A., Lister, J.
Published in Value in health (01.05.2020)
Published in Value in health (01.05.2020)
Get full text
Journal Article
EE257 Budget Consequences of Five Benign Prostatic Hyperplasia Treatment Options - US Medicare Perspective
Chughtai, B, Rojanasarot, S, Neeser, K, Gultyaev, D, Herscu, P, Fu, S, Bhattacharyya, SK, El-Arabi, A, Cutone, B, McVary, KT
Published in Value in health (01.07.2022)
Published in Value in health (01.07.2022)
Get full text
Journal Article
PUK14 COST-EFFECTIVENESS OF CONVECTIVE WATER VAPOR ENERGY THERAPY COMPARED TO PROSTATIC URETHRAL LIFT FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Neeser, K., Chughtai, B., Rojanasarot, S., Amorosi, S.L., Appah-Gyamenah, V., Gultyaev, D., Minshall, M., Shore, N.D.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
A Hospital Budget Impact Model to Estimate the Impact Associated with Phasix™ and Phasix™ St Mesh Versus Stratticetm Matrix in Complex Ventral Hernia Repair Procedures
Hofstetter, S, Hutcheson, R, Gultyaev, D, Stern, L, Tripodi, D, Corral, M
Published in Value in health (01.05.2018)
Published in Value in health (01.05.2018)
Get full text
Journal Article
PMD109 - A Hospital Budget Impact Model to Estimate the Impact Associated with Phasix™ and Phasix™ St Mesh Versus Stratticetm Matrix in Complex Ventral Hernia Repair Procedures
Hofstetter, S, Hutcheson, R, Gultyaev, D, Stern, L, Tripodi, D, Corral, M
Published in Value in health (01.05.2018)
Published in Value in health (01.05.2018)
Get full text
Journal Article
701 Cost-utility analysis of onabotulinumtoxinA versus best supportive care in the treatment of idiopathic overactive bladder with urinary incontinence among patients not adequately managed with anticholinergic therapy
Freemantle, N, Khalaf, K, Loveman, C, Stanisic, S, Gultyaev, D, Lister, J, Ng-Mak, D, Drake, M
Published in European urology supplements : official journal of the European Association of Urology (01.04.2014)
Published in European urology supplements : official journal of the European Association of Urology (01.04.2014)
Get full text
Journal Article
PUK21 - A Cost-Effectiveness Analysis Of Onabotulinumtoxina Verse. Best Supportive Care (bsc) For The Treatment Of Anticholinergic Treatment-Refractory Neurogenic Detrusor Overactivity (ndo)
Hamid, R., Loveman, C., Millen, J., Colayco, D., Stanisic, S., Gultyaev, D
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
A Cost-Effectiveness Analysis Of Onabotulinumtoxina Verse. Best Supportive Care (bsc) For The Treatment Of Anticholinergic Treatment-Refractory Neurogenic Detrusor Overactivity (ndo)
Hamid, R, Loveman, C, Millen, J, Colayco, D, Stanisic, S, Gultyaev, D
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
PCN13 - Simulation and Comparison of Progression-Free Survival (Pfs) Among Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Therapy
Chouaid, C., Walzer, S, Lister, J., Gultyaev, D., Vergnenegre, A., de Marinis, F., Meng, J., de Castro, J., Crott, R., Kleman, M., Ngoh, C.A.
Published in Value in health (01.05.2014)
Published in Value in health (01.05.2014)
Get full text
Journal Article
Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain
Lister, Johanna, Stanisic, Sanja, Kaier, Klaus, Hagist, Christian, Gultyaev, Dmitry, Walzer, Stefan
Published in ClinicoEconomics and outcomes research (2012)
Published in ClinicoEconomics and outcomes research (2012)
Get full text
Journal Article